Home › Funds › RTW INVESTMENTS, LP › RCKT
RTW INVESTMENTS, LP position in RCKT
ROCKET PHARMACEUTICALS INC · Health Care
RTW INVESTMENTS, LP reported holding 17,687,772 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$46.5M, representing 0.47% of its reported portfolio and ranking #47 among its reported holdings. RTW INVESTMENTS, LP has disclosed RCKT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's RCKT position evolved
RTW INVESTMENTS, LP first disclosed a stake in RCKT in Q3 2023 at 17,687,772 shares (US$362.4M). The position peaked in Q4 2023 at 17,687,772 shares, worth US$530.1M. Across 13 filings, RTW INVESTMENTS, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 17,687,772 shares valued at US$46.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.69M | $362.42M | New |
| Q4 2023 | 17.69M | $530.10M | Hold |
| Q1 2024 | 17.69M | $476.51M | Hold |
| Q2 2024 | 17.69M | $380.82M | Hold |
| Q3 2024 | 17.69M | $326.69M | Hold |
| Q4 2024 | 17.69M | $222.34M | Hold |
| Q1 2025 | 17.69M | $117.98M | Hold |
| Q2 2025 | 17.69M | $43.34M | Hold |
| Q3 2025 | 17.69M | $57.66M | Hold |
| Q4 2025 | 17.69M | $62.08M | Hold |
| Q1 2026 | 17.69M | $63.32M | Hold |
| Q2 2026 | 17.69M | $60.49M | Hold |
| Q3 2026 | 17.69M | $46.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RCKT and 13F data
RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 14 other funds we track also report a position in RCKT — the largest reported positions include Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M), MAVERICK CAPITAL LTD (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RCKT
- Newtyn Management, LLC 4.00M sh · $13.68M · Q2 2026
- Maverick Capital 3.92M sh · $13.42M · Q2 2026
- MAVERICK CAPITAL LTD 3.92M sh · $13.42M · Q2 2026
- Monaco Asset Management SAM 2.92M sh · $7.68M · Q3 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held RCKT?
RTW INVESTMENTS, LP has disclosed RCKT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in RCKT?
As of Q3 2026, RTW INVESTMENTS, LP holds 17.69M shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $46.52M, representing 0.47% of its reported portfolio and ranking #47.
Has RTW INVESTMENTS, LP been buying or selling RCKT?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in RCKT. The position peaked in Q4 2023 at 17.69M shares.
Which other funds hold RCKT?
Other major institutional holders of RCKT include Newtyn Management, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.